Plerixafor octahydrochloride
Cat. No.：YN321289
CAS No. ：155148-31-5
| 产品名称: | Plerixafor octahydrochloride |
| CAS No.: | 155148-31-5 |
| Chemical Name: | 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane Hydrochloride (1:8); 1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane Octahydrochloride; AMD 3100; JM 3100; SID 791; |
| Synonyms: | 盐酸普乐沙福; AMD3100 octahydrochloride; JM3100 octahydrochloride; SID791 octahydrochloride |
| 分子量: | 794.47 |
| 分子式: | C₂₈H₆₂Cl₈N₈ |
| SMILES: | [H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.[H]Cl.N1(CCCNCCNCCCNCC1)CC2=CC=C(C=C2)CN3CCCNCCNCCCNCC3 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | Plerixafor octahydrochloride (AMD3100 octahydrochloride) 是一种选择性的CXCR4拮抗剂，IC50为 44 nM。 |
| IC50和靶点: | [{name:"125I-CXCL12-CXCR4:44 nM (IC50)'}, '125I-CXCL12-CXCR7', {'HIV-1:1-10 nM (EC50)"},{name: "HIV-2:1-10 nM (EC50)"}] |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Xie, T., et al.: Science, 290, 328 (2000), Leone, D., et al.: J. Pharmacol. Exp. Ther., 305, 1150 (2003),
